"Levamisole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
| Descriptor ID |
D007978
|
| MeSH Number(s) |
D02.886.675.346 D03.383.129.308.480 D03.383.129.708.346
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Levamisole".
Below are MeSH descriptors whose meaning is more specific than "Levamisole".
This graph shows the total number of publications written about "Levamisole" by people in this website by year, and whether "Levamisole" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Levamisole" by people in Profiles.
-
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol. 1999 Nov; 17(11):3553-9.